[1] Reese C, Lee R, Bonner M, et al. Fibrocytes in the fibrotic lung: altered phenotype detected by flow cytometry. Front Pharmacol, 2014; 5, 141. doi:  10.3389/fphar.2014.00141/full
[2] Medina A, Ghahary A. Reprogrammed fibrocytes induce a mixed Th1/Th2 cytokine response of naive CD4(+) T cells. Mol Cell Biochem, 2011; 346, 89-94. doi:  10.1007/s11010-010-0595-2
[3] Moeller A, Gilpin SE, Ask K, et al. Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med, 2009; 179, 588-94. doi:  10.1164/rccm.200810-1534OC
[4] Bucala R, Spiegel LA, Chesney J, et al. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med, 1994; 1, 71-81. https://www.researchgate.net/publication/14411730_Circulating_Fibrocytes_Define_a_New_Leukocyte_Subpopulation_That_Mediates_Tissue_Repair
[5] Li J, Yao W, Hou JY, et al. Crystalline Silica Promotes Rat Fibrocyte Differentiation in Vitro, and Fibrocytes Participate in Silicosis in Vivo. Biomed Environ Sci, 2017; 30, 649-60. http://www.besjournal.com/Articles/Archive/2017/No9/201710/t20171011_154081.html
[6] Gomperts BN, Strieter RM. Fibrocytes in lung disease. J Leukoc Biol, 2007; 82, 449-56. doi:  10.1189/jlb.0906587
[7] Garcia de Alba C, Buendia-Roldan I, Salgado A, et al. Fibrocytes contribute to inflammation and fibrosis in chronic hypersensitivity pneumonitis through paracrine effects. Am J Respir Crit Care Med, 2015; 191, 427-36. doi:  10.1164/rccm.201407-1334OC
[8] Phillips RJ, Burdick MD, Hong K, et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest, 2004; 114, 438-46. doi:  10.1172/JCI200420997